Dynavax Technologies Corp (DVAX)
12.36
+0.19
(+1.56%)
USD |
NASDAQ |
Nov 21, 16:00
12.38
+0.02
(+0.12%)
After-Hours: 20:00
Dynavax Technologies Market Cap: 1.625B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.625B |
| November 20, 2024 | 1.600B |
| November 19, 2024 | 1.579B |
| November 18, 2024 | 1.537B |
| November 15, 2024 | 1.605B |
| November 14, 2024 | 1.760B |
| November 13, 2024 | 1.777B |
| November 12, 2024 | 1.775B |
| November 11, 2024 | 1.796B |
| November 08, 2024 | 1.710B |
| November 07, 2024 | 1.580B |
| November 06, 2024 | 1.616B |
| November 05, 2024 | 1.579B |
| November 04, 2024 | 1.549B |
| November 01, 2024 | 1.547B |
| October 31, 2024 | 1.556B |
| October 30, 2024 | 1.584B |
| October 29, 2024 | 1.551B |
| October 28, 2024 | 1.496B |
| October 25, 2024 | 1.407B |
| October 24, 2024 | 1.415B |
| October 23, 2024 | 1.428B |
| October 22, 2024 | 1.443B |
| October 21, 2024 | 1.442B |
| October 18, 2024 | 1.438B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.434B |
| October 16, 2024 | 1.449B |
| October 15, 2024 | 1.413B |
| October 14, 2024 | 1.374B |
| October 11, 2024 | 1.370B |
| October 10, 2024 | 1.350B |
| October 09, 2024 | 1.391B |
| October 08, 2024 | 1.396B |
| October 07, 2024 | 1.415B |
| October 04, 2024 | 1.447B |
| October 03, 2024 | 1.470B |
| October 02, 2024 | 1.491B |
| October 01, 2024 | 1.484B |
| September 30, 2024 | 1.463B |
| September 27, 2024 | 1.441B |
| September 26, 2024 | 1.422B |
| September 25, 2024 | 1.411B |
| September 24, 2024 | 1.424B |
| September 23, 2024 | 1.456B |
| September 20, 2024 | 1.487B |
| September 19, 2024 | 1.507B |
| September 18, 2024 | 1.469B |
| September 17, 2024 | 1.476B |
| September 16, 2024 | 1.461B |
| September 13, 2024 | 1.464B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
195.65M
Minimum
Mar 16 2020
2.512B
Maximum
Nov 03 2021
1.292B
Average
1.425B
Median
Market Cap Benchmarks
| Biogen Inc | 23.03B |
| Repligen Corp | 7.942B |
| West Pharmaceutical Services Inc | 23.24B |
| Janux Therapeutics Inc | 2.440B |
| XOMA Royalty Corp | 354.31M |
Market Cap Related Metrics
| PE Ratio | 95.08 |
| PS Ratio | 6.740 |
| Price to Book Value | 2.384 |
| Price to Free Cash Flow | 77.54 |
| Price | 12.36 |
| Earnings Yield | 1.05% |
| Normalized PE Ratio | 95.08 |